Correlation Between Mydecine Innovations and HAVN Life

Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and HAVN Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and HAVN Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mydecine Innovations Group and HAVN Life Sciences, you can compare the effects of market volatilities on Mydecine Innovations and HAVN Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of HAVN Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and HAVN Life.

Diversification Opportunities for Mydecine Innovations and HAVN Life

-0.24

Correlation Coefficient

Mydecine Innovations  HAVN Life

Very good diversification

The 3 months correlation between Mydecine and HAVN is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and HAVN Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HAVN Life Sciences and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with HAVN Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HAVN Life Sciences has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and HAVN Life go up and down completely randomly.

Pair Corralation between Mydecine Innovations and HAVN Life

Assuming the 90 days horizon Mydecine Innovations is expected to generate 2.05 times less return on investment than HAVN Life. But when comparing it to its historical volatility, Mydecine Innovations Group is 2.69 times less risky than HAVN Life. It trades about 0.19 of its potential returns per unit of risk. HAVN Life Sciences is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  0.10  in HAVN Life Sciences on May 5, 2025 and sell it today you would lose (0.08) from holding HAVN Life Sciences or give up 80.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.92%
Values	Daily Returns

Mydecine Innovations Group  vs.  HAVN Life Sciences

Mydecine Innovations

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

HAVN Life Sciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in HAVN Life Sciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly abnormal essential indicators, HAVN Life reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mydecine Innovations and HAVN Life

The main advantage of trading using opposite Mydecine Innovations and HAVN Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, HAVN Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HAVN Life will offset losses from the drop in HAVN Life's long position.

The idea behind Mydecine Innovations Group and HAVN Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.